▶ 調査レポート

クラミジア感染診断・治療薬の世界市場：市場規模・現状・予測
• 英文タイトル：Global Chlamydia Infection Diagnostics and Therapeutics Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。クラミジア感染診断・治療薬の世界市場：市場規模・現状・予測 / Global Chlamydia Infection Diagnostics and Therapeutics Market Size, Status and Forecast 2019-2025 / QYR9ST03607資料のイメージです。• レポートコード：QYR9ST03607
• 出版社/出版日：QYResearch / 2019年9月2日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、92ページ
• 納品方法：Eメール（受注後2-3営業日）
• 産業分類：医療・製薬
• 販売価格（消費税別）
  Single User￥577,200 (USD3,900)▷ お問い合わせ
  Enterprise License￥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
※当調査レポートでは、クラミジア感染診断・治療薬の世界市場について調査・分析し、クラミジア感染診断・治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（核酸増幅試験（NAAT）、直接蛍光試験、マクロライド、キノロン、スルホンアミド、テトラサイクリン、アミノペニシリン）、用途別（病院、専門診療所、診断センター、治療薬、病院薬局、ドラッグストア、小売薬局、オンライン薬局）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。


・レポートの概要
・世界のクラミジア感染診断・治療薬市場動向
・主要企業別マーケットシェア
・クラミジア感染診断・治療薬の種類別市場規模2014-2019
（核酸増幅試験（NAAT）、直接蛍光試験、マクロライド、キノロン、スルホンアミド、テトラサイクリン、アミノペニシリン）
・クラミジア感染診断・治療薬の用途別市場規模2014-2019
（病院、専門診療所、診断センター、治療薬、病院薬局、ドラッグストア、小売薬局、オンライン薬局）
・クラミジア感染診断・治療薬の北米市場：主要企業・種類別/用途別市場規模
・クラミジア感染診断・治療薬のヨーロッパ市場：主要企業・種類別/用途別市場規模
・クラミジア感染診断・治療薬の中国市場：主要企業・種類別/用途別市場規模
・クラミジア感染診断・治療薬の日本国内市場：主要企業・種類別/用途別市場規模
・クラミジア感染診断・治療薬の東南アジア市場：主要企業・種類別/用途別市場規模
・クラミジア感染診断・治療薬のインド市場：主要企業・種類別/用途別市場規模
・クラミジア感染診断・治療薬の中南米市場：主要企業・種類別/用途別市場規模
・主要企業のプロフィール
（Bio Rad、Novartis、Roche、Abbott、Danaher、BioMerieux、DiaSorin、Siemens、Thermo Fisher、Becton Dickinson）
・クラミジア感染診断・治療薬の市場規模予測2019-2025
（種類別、用途別、地域別市場予測）
・アナリストの観点・結論
...

The chlamydia infection diagnostics and therapeutics market unveils high potential owing to the rapidly rising patient pool and vast untapped opportunities.In 2018, the global Chlamydia Infection Diagnostics and Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Chlamydia Infection Diagnostics and Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Chlamydia Infection Diagnostics and Therapeutics development in United States, Europe and China.

The key players covered in this study
Bio Rad
Novartis
Roche
Abbott
Danaher
BioMerieux
DiaSorin
Siemens
Thermo Fisher
Becton Dickinson

Market segment by Type, the product can be split into
Nucleic Acid Amplification Tests (NAATs)
Direct Fluorescent Tests
Macrolides
Quinolones
Sulfonamides
Tetracycline
Aminopenicillins

Market segment by Application, split into
Hospitals
Specialty Clinics
Diagnostic Centers Therapeutics
Hospital Pharmacies
Drugstores
Retail Pharmacies
Online Pharmacies

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Chlamydia Infection Diagnostics and Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Chlamydia Infection Diagnostics and Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Chlamydia Infection Diagnostics and Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Chlamydia Infection Diagnostics and Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Nucleic Acid Amplification Tests (NAATs)
1.4.3 Direct Fluorescent Tests
1.4.4 Macrolides
1.4.5 Quinolones
1.4.6 Sulfonamides
1.4.7 Tetracycline
1.4.8 Aminopenicillins
1.5 Market by Application
1.5.1 Global Chlamydia Infection Diagnostics and Therapeutics Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Specialty Clinics
1.5.4 Diagnostic Centers Therapeutics
1.5.5 Hospital Pharmacies
1.5.6 Drugstores
1.5.7 Retail Pharmacies
1.5.8 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Chlamydia Infection Diagnostics and Therapeutics Market Size
2.2 Chlamydia Infection Diagnostics and Therapeutics Growth Trends by Regions
2.2.1 Chlamydia Infection Diagnostics and Therapeutics Market Size by Regions (2014-2025)
2.2.2 Chlamydia Infection Diagnostics and Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Chlamydia Infection Diagnostics and Therapeutics Market Size by Manufacturers
3.1.1 Global Chlamydia Infection Diagnostics and Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Chlamydia Infection Diagnostics and Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Chlamydia Infection Diagnostics and Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Chlamydia Infection Diagnostics and Therapeutics Key Players Head office and Area Served
3.3 Key Players Chlamydia Infection Diagnostics and Therapeutics Product/Solution/Service
3.4 Date of Enter into Chlamydia Infection Diagnostics and Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Chlamydia Infection Diagnostics and Therapeutics Market Size by Type (2014-2019)
4.2 Global Chlamydia Infection Diagnostics and Therapeutics Market Size by Application (2014-2019)

5 United States
5.1 United States Chlamydia Infection Diagnostics and Therapeutics Market Size (2014-2019)
5.2 Chlamydia Infection Diagnostics and Therapeutics Key Players in United States
5.3 United States Chlamydia Infection Diagnostics and Therapeutics Market Size by Type
5.4 United States Chlamydia Infection Diagnostics and Therapeutics Market Size by Application

6 Europe
6.1 Europe Chlamydia Infection Diagnostics and Therapeutics Market Size (2014-2019)
6.2 Chlamydia Infection Diagnostics and Therapeutics Key Players in Europe
6.3 Europe Chlamydia Infection Diagnostics and Therapeutics Market Size by Type
6.4 Europe Chlamydia Infection Diagnostics and Therapeutics Market Size by Application

7 China
7.1 China Chlamydia Infection Diagnostics and Therapeutics Market Size (2014-2019)
7.2 Chlamydia Infection Diagnostics and Therapeutics Key Players in China
7.3 China Chlamydia Infection Diagnostics and Therapeutics Market Size by Type
7.4 China Chlamydia Infection Diagnostics and Therapeutics Market Size by Application

8 Japan
8.1 Japan Chlamydia Infection Diagnostics and Therapeutics Market Size (2014-2019)
8.2 Chlamydia Infection Diagnostics and Therapeutics Key Players in Japan
8.3 Japan Chlamydia Infection Diagnostics and Therapeutics Market Size by Type
8.4 Japan Chlamydia Infection Diagnostics and Therapeutics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Chlamydia Infection Diagnostics and Therapeutics Market Size (2014-2019)
9.2 Chlamydia Infection Diagnostics and Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Chlamydia Infection Diagnostics and Therapeutics Market Size by Type
9.4 Southeast Asia Chlamydia Infection Diagnostics and Therapeutics Market Size by Application

10 India
10.1 India Chlamydia Infection Diagnostics and Therapeutics Market Size (2014-2019)
10.2 Chlamydia Infection Diagnostics and Therapeutics Key Players in India
10.3 India Chlamydia Infection Diagnostics and Therapeutics Market Size by Type
10.4 India Chlamydia Infection Diagnostics and Therapeutics Market Size by Application

11 Central & South America
11.1 Central & South America Chlamydia Infection Diagnostics and Therapeutics Market Size (2014-2019)
11.2 Chlamydia Infection Diagnostics and Therapeutics Key Players in Central & South America
11.3 Central & South America Chlamydia Infection Diagnostics and Therapeutics Market Size by Type
11.4 Central & South America Chlamydia Infection Diagnostics and Therapeutics Market Size by Application

12 International Players Profiles
12.1 Bio Rad
12.1.1 Bio Rad Company Details
12.1.2 Company Description and Business Overview
12.1.3 Chlamydia Infection Diagnostics and Therapeutics Introduction
12.1.4 Bio Rad Revenue in Chlamydia Infection Diagnostics and Therapeutics Business (2014-2019)
12.1.5 Bio Rad Recent Development
12.2 Novartis
12.2.1 Novartis Company Details
12.2.2 Company Description and Business Overview
12.2.3 Chlamydia Infection Diagnostics and Therapeutics Introduction
12.2.4 Novartis Revenue in Chlamydia Infection Diagnostics and Therapeutics Business (2014-2019)
12.2.5 Novartis Recent Development
12.3 Roche
12.3.1 Roche Company Details
12.3.2 Company Description and Business Overview
12.3.3 Chlamydia Infection Diagnostics and Therapeutics Introduction
12.3.4 Roche Revenue in Chlamydia Infection Diagnostics and Therapeutics Business (2014-2019)
12.3.5 Roche Recent Development
12.4 Abbott
12.4.1 Abbott Company Details
12.4.2 Company Description and Business Overview
12.4.3 Chlamydia Infection Diagnostics and Therapeutics Introduction
12.4.4 Abbott Revenue in Chlamydia Infection Diagnostics and Therapeutics Business (2014-2019)
12.4.5 Abbott Recent Development
12.5 Danaher
12.5.1 Danaher Company Details
12.5.2 Company Description and Business Overview
12.5.3 Chlamydia Infection Diagnostics and Therapeutics Introduction
12.5.4 Danaher Revenue in Chlamydia Infection Diagnostics and Therapeutics Business (2014-2019)
12.5.5 Danaher Recent Development
12.6 BioMerieux
12.6.1 BioMerieux Company Details
12.6.2 Company Description and Business Overview
12.6.3 Chlamydia Infection Diagnostics and Therapeutics Introduction
12.6.4 BioMerieux Revenue in Chlamydia Infection Diagnostics and Therapeutics Business (2014-2019)
12.6.5 BioMerieux Recent Development
12.7 DiaSorin
12.7.1 DiaSorin Company Details
12.7.2 Company Description and Business Overview
12.7.3 Chlamydia Infection Diagnostics and Therapeutics Introduction
12.7.4 DiaSorin Revenue in Chlamydia Infection Diagnostics and Therapeutics Business (2014-2019)
12.7.5 DiaSorin Recent Development
12.8 Siemens
12.8.1 Siemens Company Details
12.8.2 Company Description and Business Overview
12.8.3 Chlamydia Infection Diagnostics and Therapeutics Introduction
12.8.4 Siemens Revenue in Chlamydia Infection Diagnostics and Therapeutics Business (2014-2019)
12.8.5 Siemens Recent Development
12.9 Thermo Fisher
12.9.1 Thermo Fisher Company Details
12.9.2 Company Description and Business Overview
12.9.3 Chlamydia Infection Diagnostics and Therapeutics Introduction
12.9.4 Thermo Fisher Revenue in Chlamydia Infection Diagnostics and Therapeutics Business (2014-2019)
12.9.5 Thermo Fisher Recent Development
12.10 Becton Dickinson
12.10.1 Becton Dickinson Company Details
12.10.2 Company Description and Business Overview
12.10.3 Chlamydia Infection Diagnostics and Therapeutics Introduction
12.10.4 Becton Dickinson Revenue in Chlamydia Infection Diagnostics and Therapeutics Business (2014-2019)
12.10.5 Becton Dickinson Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Chlamydia Infection Diagnostics and Therapeutics Key Market Segments
Table Key Players Chlamydia Infection Diagnostics and Therapeutics Covered
Table Global Chlamydia Infection Diagnostics and Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Chlamydia Infection Diagnostics and Therapeutics Market Size Market Share by Type 2014-2025
Figure Nucleic Acid Amplification Tests (NAATs) Figures
Table Key Players of Nucleic Acid Amplification Tests (NAATs)
Figure Direct Fluorescent Tests Figures
Table Key Players of Direct Fluorescent Tests
Figure Macrolides Figures
Table Key Players of Macrolides
Figure Quinolones Figures
Table Key Players of Quinolones
Figure Sulfonamides Figures
Table Key Players of Sulfonamides
Figure Tetracycline Figures
Table Key Players of Tetracycline
Figure Aminopenicillins Figures
Table Key Players of Aminopenicillins
Table Global Chlamydia Infection Diagnostics and Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Specialty Clinics Case Studies
Figure Diagnostic Centers Therapeutics Case Studies
Figure Hospital Pharmacies Case Studies
Figure Drugstores Case Studies
Figure Retail Pharmacies Case Studies
Figure Online Pharmacies Case Studies
Figure Chlamydia Infection Diagnostics and Therapeutics Report Years Considered
Table Global Chlamydia Infection Diagnostics and Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Chlamydia Infection Diagnostics and Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Chlamydia Infection Diagnostics and Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Chlamydia Infection Diagnostics and Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Chlamydia Infection Diagnostics and Therapeutics Market Share by Regions 2014-2019
Figure Global Chlamydia Infection Diagnostics and Therapeutics Market Share by Regions 2014-2019
Figure Global Chlamydia Infection Diagnostics and Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Chlamydia Infection Diagnostics and Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Chlamydia Infection Diagnostics and Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Chlamydia Infection Diagnostics and Therapeutics Market Share by Manufacturers in 2018
Table Global Chlamydia Infection Diagnostics and Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Chlamydia Infection Diagnostics and Therapeutics Product/Solution/Service
Table Date of Enter into Chlamydia Infection Diagnostics and Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Chlamydia Infection Diagnostics and Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Chlamydia Infection Diagnostics and Therapeutics Market Size Share by Type (2014-2019)
Figure Global Chlamydia Infection Diagnostics and Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Chlamydia Infection Diagnostics and Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Chlamydia Infection Diagnostics and Therapeutics Market Size Share by Application (2014-2019)
Figure Global Chlamydia Infection Diagnostics and Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Chlamydia Infection Diagnostics and Therapeutics Revenue Market Share by Application in 2018
Figure United States Chlamydia Infection Diagnostics and Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Chlamydia Infection Diagnostics and Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Chlamydia Infection Diagnostics and Therapeutics Market Share (2018-2019)
Table United States Chlamydia Infection Diagnostics and Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Chlamydia Infection Diagnostics and Therapeutics Market Share by Type (2014-2019)
Table United States Chlamydia Infection Diagnostics and Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Chlamydia Infection Diagnostics and Therapeutics Market Share by Application (2014-2019)
Figure Europe Chlamydia Infection Diagnostics and Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Chlamydia Infection Diagnostics and Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Chlamydia Infection Diagnostics and Therapeutics Market Share (2018-2019)
Table Europe Chlamydia Infection Diagnostics and Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Chlamydia Infection Diagnostics and Therapeutics Market Share by Type (2014-2019)
Table Europe Chlamydia Infection Diagnostics and Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Chlamydia Infection Diagnostics and Therapeutics Market Share by Application (2014-2019)
Figure China Chlamydia Infection Diagnostics and Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Chlamydia Infection Diagnostics and Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Chlamydia Infection Diagnostics and Therapeutics Market Share (2018-2019)
Table China Chlamydia Infection Diagnostics and Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Chlamydia Infection Diagnostics and Therapeutics Market Share by Type (2014-2019)
Table China Chlamydia Infection Diagnostics and Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Chlamydia Infection Diagnostics and Therapeutics Market Share by Application (2014-2019)
Figure Japan Chlamydia Infection Diagnostics and Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Chlamydia Infection Diagnostics and Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Chlamydia Infection Diagnostics and Therapeutics Market Share (2018-2019)
Table Japan Chlamydia Infection Diagnostics and Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Chlamydia Infection Diagnostics and Therapeutics Market Share by Type (2014-2019)
Table Japan Chlamydia Infection Diagnostics and Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Chlamydia Infection Diagnostics and Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Chlamydia Infection Diagnostics and Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Chlamydia Infection Diagnostics and Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Chlamydia Infection Diagnostics and Therapeutics Market Share (2018-2019)
Table Southeast Asia Chlamydia Infection Diagnostics and Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Chlamydia Infection Diagnostics and Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Chlamydia Infection Diagnostics and Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Chlamydia Infection Diagnostics and Therapeutics Market Share by Application (2014-2019)
Figure India Chlamydia Infection Diagnostics and Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Chlamydia Infection Diagnostics and Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Chlamydia Infection Diagnostics and Therapeutics Market Share (2018-2019)
Table India Chlamydia Infection Diagnostics and Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Chlamydia Infection Diagnostics and Therapeutics Market Share by Type (2014-2019)
Table India Chlamydia Infection Diagnostics and Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Chlamydia Infection Diagnostics and Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Chlamydia Infection Diagnostics and Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Chlamydia Infection Diagnostics and Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Chlamydia Infection Diagnostics and Therapeutics Market Share (2018-2019)
Table Central & South America Chlamydia Infection Diagnostics and Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Chlamydia Infection Diagnostics and Therapeutics Market Share by Type (2014-2019)
Table Central & South America Chlamydia Infection Diagnostics and Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Chlamydia Infection Diagnostics and Therapeutics Market Share by Application (2014-2019)
Table Bio Rad Company Details
Table Bio Rad Revenue in Chlamydia Infection Diagnostics and Therapeutics Business (2014-2019) (Million US$)
Figure Bio Rad Revenue Growth Rate in Chlamydia Infection Diagnostics and Therapeutics Business (2014-2019)
Table Bio Rad Recent Development
Table Novartis Company Details
Table Novartis Revenue in Chlamydia Infection Diagnostics and Therapeutics Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Chlamydia Infection Diagnostics and Therapeutics Business (2014-2019)
Table Novartis Recent Development
Table Roche Company Details
Table Roche Revenue in Chlamydia Infection Diagnostics and Therapeutics Business (2014-2019)(Million US$)
Figure Roche Revenue Growth Rate in Chlamydia Infection Diagnostics and Therapeutics Business (2014-2019)
Table Roche Recent Development
Table Abbott Company Details
Table Abbott Revenue in Chlamydia Infection Diagnostics and Therapeutics Business (2014-2019)(Million US$)
Figure Abbott Revenue Growth Rate in Chlamydia Infection Diagnostics and Therapeutics Business (2014-2019)
Table Abbott Recent Development
Table Danaher Company Details
Table Danaher Revenue in Chlamydia Infection Diagnostics and Therapeutics Business (2014-2019)(Million US$)
Figure Danaher Revenue Growth Rate in Chlamydia Infection Diagnostics and Therapeutics Business (2014-2019)
Table Danaher Recent Development
Table BioMerieux Company Details
Table BioMerieux Revenue in Chlamydia Infection Diagnostics and Therapeutics Business (2014-2019)(Million US$)
Figure BioMerieux Revenue Growth Rate in Chlamydia Infection Diagnostics and Therapeutics Business (2014-2019)
Table BioMerieux Recent Development
Table DiaSorin Company Details
Table DiaSorin Revenue in Chlamydia Infection Diagnostics and Therapeutics Business (2014-2019)(Million US$)
Figure DiaSorin Revenue Growth Rate in Chlamydia Infection Diagnostics and Therapeutics Business (2014-2019)
Table DiaSorin Recent Development
Table Siemens Company Details
Table Siemens Revenue in Chlamydia Infection Diagnostics and Therapeutics Business (2014-2019)(Million US$)
Figure Siemens Revenue Growth Rate in Chlamydia Infection Diagnostics and Therapeutics Business (2014-2019)
Table Siemens Recent Development
Table Thermo Fisher Company Details
Table Thermo Fisher Revenue in Chlamydia Infection Diagnostics and Therapeutics Business (2014-2019)(Million US$)
Figure Thermo Fisher Revenue Growth Rate in Chlamydia Infection Diagnostics and Therapeutics Business (2014-2019)
Table Thermo Fisher Recent Development
Table Becton Dickinson Company Details
Table Becton Dickinson Revenue in Chlamydia Infection Diagnostics and Therapeutics Business (2014-2019)(Million US$)
Figure Becton Dickinson Revenue Growth Rate in Chlamydia Infection Diagnostics and Therapeutics Business (2014-2019)
Table Becton Dickinson Recent Development
Table Global Chlamydia Infection Diagnostics and Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Chlamydia Infection Diagnostics and Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Chlamydia Infection Diagnostics and Therapeutics Market Size Share by Regions in 2025
Figure United States Chlamydia Infection Diagnostics and Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Chlamydia Infection Diagnostics and Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Chlamydia Infection Diagnostics and Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Chlamydia Infection Diagnostics and Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Chlamydia Infection Diagnostics and Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Chlamydia Infection Diagnostics and Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Chlamydia Infection Diagnostics and Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Chlamydia Infection Diagnostics and Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Chlamydia Infection Diagnostics and Therapeutics Market Size by Product (2019-2025)
Figure Global Chlamydia Infection Diagnostics and Therapeutics Market Size by Product in 2025
Table Global Chlamydia Infection Diagnostics and Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Chlamydia Infection Diagnostics and Therapeutics Market Size by Application (2019-2025)
Figure Global Chlamydia Infection Diagnostics and Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介
  • 急性骨髄性白血病（AML）治療薬の世界市場：市場規模・現状・予測
    Global Acute Myeloid Leukemia (AML) Therapeutics Market Size, Status and Forecast 2019-2025
    QYR9ST03568 2019年9月2日 96Pages
    ※当調査レポートでは、急性骨髄性白血病（AML）治療薬の世界市場について調査・分析し、急性骨髄性白血病（AML）治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（化学療法、放射線療法、幹細胞移植...
  • 末梢動脈疾患（PAD）治療薬の世界市場：市場規模・現状・予測
    Global Peripheral Arterial Disease (PAD) Therapeutics Market Size, Status and Forecast 2019-2025
    QYR9ST04523 2019年9月2日 99Pages
    ※当調査レポートでは、末梢動脈疾患（PAD）治療薬の世界市場について調査・分析し、末梢動脈疾患（PAD）治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（抗血小板薬、二重抗血小板療法薬、その他）...
  • 急性骨髄性白血病（AML）治療薬の世界市場：市場規模・現状・予測
    Global Acute Myeloid Leukemia Therapeutics Market Size, Status and Forecast 2019-2025
    QYR9ST04687 2019年9月2日 90Pages
    ※当調査レポートでは、急性骨髄性白血病（AML）治療薬の世界市場について調査・分析し、急性骨髄性白血病（AML）治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（パイプライン薬、化学療法薬、化学...
  • 急性リンパ性/リンパ芽球性白血病（ALL）治療薬の世界市場：市場規模・現状・予測
    Global Acute Lymphocytic/Lymphoblastic Leukemia (ALL) Therapeutics Market Size, Status and Forecast 2019-2025
    QYR9ST05752 2019年9月2日 96Pages
    ※当調査レポートでは、急性リンパ性/リンパ芽球性白血病（ALL）治療薬の世界市場について調査・分析し、急性リンパ性/リンパ芽球性白血病（ALL）治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（...
  • 急性リンパ性/リンパ芽球性白血病（ALL）治療薬の世界市場：市場規模・現状・予測
    Global Acute Lymphocytic/Lymphoblastic Leukemia (ALL) Therapeutics Market Size, Status and Forecast 2019-2025
    QYR9ST05752 2019年9月2日 96Pages
    ※当調査レポートでは、急性リンパ性/リンパ芽球性白血病（ALL）治療薬の世界市場について調査・分析し、急性リンパ性/リンパ芽球性白血病（ALL）治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（...
  • 注意欠陥多動性障害（ADHD）治療薬の世界市場：市場規模・現状・予測
    Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size, Status and Forecast 2019-2025
    QYR9ST04380 2019年9月2日 93Pages
    ※当調査レポートでは、注意欠陥多動性障害（ADHD）治療薬の世界市場について調査・分析し、注意欠陥多動性障害（ADHD）治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（覚せい剤、非興奮剤）、用...
  • ペプチドベース感染治療薬の世界市場：市場規模・現状・予測
    Global Peptide Based Infection Therapeutics Market Size, Status and Forecast 2019-2025
    QYR9ST03972 2019年9月2日 97Pages
    ※当調査レポートでは、ペプチドベース感染治療薬の世界市場について調査・分析し、ペプチドベース感染治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（テラプレビル、ソフォスブビル、その他）、用途別（...
  • 院内感染治療薬の世界市場：市場規模・現状・予測
    Global Hospital Infection Therapeutics Market Size, Status and Forecast 2019-2025
    QYR9ST05289 2019年9月2日 90Pages
    ※当調査レポートでは、院内感染治療薬の世界市場について調査・分析し、院内感染治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（抗菌薬、抗ウイルス薬、抗真菌薬）、用途別（院内感染肺炎、手術部位感染...
  • 院内感染治療薬の世界市場：市場規模・現状・予測
    Global Hospital Infection Therapeutics Market Size, Status and Forecast 2019-2025
    QYR9ST05289 2019年9月2日 90Pages
    ※当調査レポートでは、院内感染治療薬の世界市場について調査・分析し、院内感染治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（抗菌薬、抗ウイルス薬、抗真菌薬）、用途別（院内感染肺炎、手術部位感染...
  • 睡眠時無呼吸診断及び治療の世界市場：市場規模・現状・予測
    Global Sleep Apnea Diagnostics and Therapeutics Market Size, Status and Forecast 2019-2025
    QYR9ST05034 2019年9月2日 91Pages
    ※当調査レポートでは、睡眠時無呼吸診断及び治療の世界市場について調査・分析し、睡眠時無呼吸診断及び治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（ポリソムノグラフィ（PSG）デバイス、アクチグラ...